Showing results (431-440 of 631) with videos related to
Sort By:
Pageof 64
The Journal of Clinical Investigation|July 17, 1998
Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout miceP Holvoet, S Danloy, E Deridder, et al.Proceedings of the National Academy of Sciences of the United States of America|July 8, 1999
Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestationJ Erlich, G C Parry, C Fearns, et al.Endocrinology|June 1, 1990
Interferon-gamma inhibits stimulated adrenocorticotropin, prolactin, and growth hormone secretion in normal rat anterior pituitary cell culturesH Vankelecom, P Carmeliet, H Heremans, et al.Thrombosis and Haemostasis|October 6, 1997
Characterization and targeting of the murine alpha2-antiplasmin geneK Okada, H R Lijnen, M Dewerchin, et al.The Journal of Biological Chemistry|November 25, 1987
Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3M J Heeb, F España, M Geiger, et al.Thrombosis and Haemostasis|November 1, 1996
Functional significance of NH2- and COOH-terminal regions of staphylokinase in plasminogen activationA Gase, M Hartmann, K H Gührs, et al.Science (New York, N.Y.)|June 10, 1983
Clot-selective coronary thrombolysis with tissue-type plasminogen activatorS R Bergmann, K A Fox, M M Ter-Pogossian, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|December 11, 1999
Accelerated neointima formation after vascular injury in mice with stromelysin-3 (MMP-11) gene inactivationH R Lijnen, B Van Hoef, I Vanlinthout, et al.Thrombosis and Haemostasis|April 2, 1992
Biochemical, thrombolytic and pharmacokinetic properties of rt-PA P47G, K49N, a substitution variant of human tissue-type plasminogen activatorL Nelles, X K Li, I Vanlinthout, et al.Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Recombinant human microplasmin: production and potential therapeutic propertiesN Nagai, E Demarsin, B Van Hoef, et al.Pageof 64